coronavirus
University monitoring coronavirus outbreak
Jan. 29, 2020—Vanderbilt University officials are actively monitoring the outbreak of the respiratory illness caused by a novel (new) coronavirus first identified in Wuhan, China. At this time, there are no reports of coronavirus cases on the Vanderbilt campus, and there are no confirmed cases in Tennessee.
Team investigates antiviral that inhibits SARS, MERS
Jun. 29, 2017—A new antiviral drug candidate inhibits a broad range of coronaviruses, including the SARS and MERS coronaviruses, a multi-institutional team of investigators reports this week in Science Translational Medicine.
Keep your coat on, virus!
Sep. 22, 2015—A compound acting on serotonin receptors delays a critical step during reovirus cell entry, reducing viral infectivity.
Contributors to coronavirus ‘fitness’
Feb. 24, 2015—Understanding the role that host membrane modification plays in coronavirus replication is essential for developing novel approaches to block the viruses that cause SARS and MERS.
‘Proofreader’ key to coronavirus growth
Sep. 12, 2013—A coronavirus protein is required for replication of the viral genome and may be a good treatment target for SARS and other diseases caused by coronaviruses.
UNC, Vanderbilt discover a new live vaccine approach for SARS and novel coronaviruses
Nov. 12, 2012—Collaborating researchers at the University of North Carolina and Vanderbilt University have found that accelerating the rate of mutations in the coronavirus responsible for deadly severe acute respiratory syndrome (SARS) cripples the virus’s ability to cause disease in animals.